human STIM1 CFP Citations (11)
Originally described in: Orai1 is an essential pore subunit of the CRAC channel.Prakriya M, Feske S, Gwack Y, Srikanth S, Rao A, Hogan PG Nature. 2006 Sep 14. 443(7108):230-3. PubMed Journal
Articles Citing human STIM1 CFP
| Articles |
|---|
| Human muscle economy myoblast differentiation and excitation-contraction coupling use the same molecular partners, STIM1 and STIM2. Darbellay B, Arnaudeau S, Ceroni D, Bader CR, Konig S, Bernheim L. J Biol Chem. 2010 Jul 16;285(29):22437-47. doi: 10.1074/jbc.M110.118984. Epub 2010 May 1. PubMed |
| STIM1 negatively regulates Ca(2)(+) release from the sarcoplasmic reticulum in skeletal myotubes. Lee KJ, Woo JS, Hwang JH, Hyun C, Cho CH, Kim do H, Lee EH. Biochem J. 2013 Jul 15;453(2):187-200. doi: 10.1042/BJ20130178. PubMed |
| Stromal interaction molecule 1 (STIM1) regulates sarcoplasmic/endoplasmic reticulum Ca(2)(+)-ATPase 1a (SERCA1a) in skeletal muscle. Lee KJ, Hyun C, Woo JS, Park CS, Kim do H, Lee EH. Pflugers Arch. 2014 May;466(5):987-1001. PubMed |
Light generation of intracellular Ca(2+) signals by a genetically encoded protein BACCS.
Ishii T, Sato K, Kakumoto T, Miura S, Touhara K, Takeuchi S, Nakata T.
Nat Commun. 2015 Aug 18;6:8021. doi: 10.1038/ncomms9021.
PubMed
Associated Plasmids |
| Inhibition of the NEDD8 conjugation pathway induces calcium-dependent compensatory activation of the pro-survival MEK/ERK pathway in acute lymphoblastic leukemia. Zheng S, Leclerc GM, Li B, Swords RT, Barredo JC. Oncotarget. 2017 Dec 31;9(5):5529-5544. doi: 10.18632/oncotarget.23797. eCollection 2018 Jan 19. PubMed |
| The CCT chaperonin is a novel regulator of Ca(2+) signaling through modulation of Orai1 trafficking. Hodeify R, Nandakumar M, Own M, Courjaret RJ, Graumann J, Hubrack SZ, Machaca K. Sci Adv. 2018 Sep 26;4(9):eaau1935. doi: 10.1126/sciadv.aau1935. eCollection 2018 Sep. PubMed |
| ORAI1, STIM1/2, and RYR1 shape subsecond Ca(2+) microdomains upon T cell activation. Diercks BP, Werner R, Weidemuller P, Czarniak F, Hernandez L, Lehmann C, Rosche A, Kruger A, Kaufmann U, Vaeth M, Failla AV, Zobiak B, Kandil FI, Schetelig D, Ruthenbeck A, Meier C, Lodygin D, Flugel A, Ren D, Wolf IMA, Feske S, Guse AH. Sci Signal. 2018 Dec 18;11(561). pii: 11/561/eaat0358. doi: 10.1126/scisignal.aat0358. PubMed |
| Notch enhances Ca(2+) entry by activating calcium-sensing receptors and inhibiting voltage-gated K(+) channels. Song S, Babicheva A, Zhao T, Ayon RJ, Rodriguez M, Rahimi S, Balistrieri F, Harrington A, Shyy JY, Thistlethwaite PA, Makino A, Yuan JX. Am J Physiol Cell Physiol. 2020 May 1;318(5):C954-C968. doi: 10.1152/ajpcell.00487.2019. Epub 2020 Mar 18. PubMed |
| Identification of pimavanserin tartrate as a potent Ca(2+)-calcineurin-NFAT pathway inhibitor for glioblastoma therapy. Liu ZZ, Liu XN, Fan RC, Jia YP, Zhang QK, Gao XQ, Wang YQ, Yang MQ, Ji LZ, Zhou YQ, Li HL, Li P, Tang B. Acta Pharmacol Sin. 2021 Nov;42(11):1860-1874. doi: 10.1038/s41401-021-00724-2. Epub 2021 Aug 6. PubMed |
| Orai1alpha, but not Orai1beta, co-localizes with TRPC1 and is required for its plasma membrane location and activation in HeLa cells. Sanchez-Collado J, Lopez JJ, Jardin I, Berna-Erro A, Camello PJ, Cantonero C, Smani T, Salido GM, Rosado JA. Cell Mol Life Sci. 2022 Jan 6;79(1):33. doi: 10.1007/s00018-021-04098-w. PubMed |
| EHD2 overexpression promotes tumorigenesis and metastasis in triple-negative breast cancer by regulating store-operated calcium entry. Luan H, Bielecki TA, Mohapatra BC, Islam N, Mushtaq I, Bhat AM, Mirza S, Chakraborty S, Raza M, Storck MD, Toss MS, Meza JL, Thoreson WB, Coulter DW, Rakha EA, Band V, Band H. Elife. 2023 Jan 10;12:e81288. doi: 10.7554/eLife.81288. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.